Media contact: Hannah Echols, echolsh@uab.edu
Anath Shalev, M.D.
Division of Endocrinology, Diabetes & Metabolism
Areas of expertise:
- Diabetes research, drug discovery, and novel treatment approaches
- Beta cell and islet biology
- Type 1 diabetes
- Type 2 diabetes
- microRNAs
Shalev is an expert in the field of diabetes and in developing disease-changing therapy regimens. She is the director of UAB’s Comprehensive Diabetes Center and her research includes basic, translational and clinical work as it relates to the study of diabetes.
Media appearances:
- Targeting a microRNA could improve diabetes treatment with GLP-1 drugs, FierceBiotech
- Diabetics who use verapamil have lower glucose levels, data show, Science Daily